Pfizer

The race for gold: Closing in on the first RSV vaccine
The race for gold: Closing in on the first RSV vaccine
Pharmaphorum
vaccines
RSV
GSK
Pfizer
Moderna Therapeutics
Flag link:
Pfizer kicks newly acquired meds out of Arena as part of midstage cleaning
Pfizer kicks newly acquired meds out of Arena as part of midstage cleaning
Fierce Biotech
Pfizer
Arena Pharmaceuticals
etrasimod
M&A
Flag link:
Pfizer reports strong Q1 earnings, including $18.3B in revenues
Pfizer reports strong Q1 earnings, including $18.3B in revenues
Medical Marketing and Media
Pfizer
earnings
COVID-19
vaccines
Paxlovid
Flag link:
Pfizer, Astellas' Xtandi combo cuts risk of death by 58% in prostate cancer patients
Pfizer, Astellas' Xtandi combo cuts risk of death by 58% in prostate cancer patients
Seeking Alpha
Pfizer
Astellas
Xtandi
prostate cancer
clinical trials
Flag link:
Pfizer wins FDA nod for Prevnar 20 pneumonia vaccine in children
Pfizer wins FDA nod for Prevnar 20 pneumonia vaccine in children
Seeking Alpha
Pfizer
vaccines
FDA
Prevnar 20
pneumococcal disease
pediatric
Flag link:
The FTC put pharma giants on notice for deceptive marketing claims. But does it actually have the authority?
The FTC put pharma giants on notice for deceptive marketing claims. But does it actually have the authority?
Medical Marketing and Media
FTC
pharma marketing
deceptive marketing
JNJ
Pfizer
Flag link:
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access
Fierce Pharma
AbbVie
Amgen
Bristol Myers Squibb
Eli Lilly
Gilead Sceinces
JNJ
Merck
Pfizer
Regeneron
patents
activists
Flag link:
AstraZeneca overtakes Pfizer as crunch week for UK pharma looms
AstraZeneca overtakes Pfizer as crunch week for UK pharma looms
The Guardian, UK
AstraZeneca
Pfizer
earnings
Flag link:
Why Did Pfizer Offload This Potential Mega-Blockbuster Drug?
Why Did Pfizer Offload This Potential Mega-Blockbuster Drug?
Motley Fool
Pfizer
Roivant
IBD
RVT-3101
Flag link:
Drugmakers take sides in Amgen, Regeneron fight over antibody patents
Drugmakers take sides in Amgen, Regeneron fight over antibody patents
BioPharma Dive
Amgen
Regeneron Pharmaceuticals
Sanofi
Supreme Court
patents
Pfizer
Bayer
Roche
Genentech
AstraZeneca
JNJ
Flag link:
Big pharma holds steady on research spending
Big pharma holds steady on research spending
EP Vantage
R&D
AbbVie
Amgen
AstraZeneca
Bayer
Biogen
Bristol Myers Squibb
Eli Lilly
Gilead Sciences
GSK
JNJ
Merck
Merck KGaA
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
UCB
Vertex Pharmaceuticals
Flag link:
Big pharma’s biggest spenders revealed: 2022 edition
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
M&A
R&D
AbbVie
AstraZeneca
Bristol Myers Squibb
Eli Lilly
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
Flag link:
In Pfizer's $43B acquisition of Seagen, the biotech's patience paid off
In Pfizer's $43B acquisition of Seagen, the biotech's patience paid off
Fierce Pharma
Pfizer
Seagen
M&A
Merck
Flag link:
Pfizer signs strategic cooperation pact with China's Sinopharm
Pfizer signs strategic cooperation pact with China's Sinopharm
Yahoo/Reuters
Pfizer
Sinopharm
China
Flag link:
Can Pfizer Beat GSK and Moderna in This $10 Billion Market?
Can Pfizer Beat GSK and Moderna in This $10 Billion Market?
Motley Fool
Pfizer
GSK
Moderna Therapeutics
Flag link:
Pfizer's fortunes overshadow first-quarter dealmaking
Pfizer's fortunes overshadow first-quarter dealmaking
EP Vantage
M&A
Pfizer
Seagen
Sanofi
Provention Bio
AstraZeneca
CinCor
Chiesi
Amryt
Ipsen
Albireo
Flag link:
Biotech layoffs gather pace as industry downturn persists
Biotech layoffs gather pace as industry downturn persists
BioPharma Dive
layoffs
biotech
Amgen
Pfizer
Roche
Jounce Therapeutics
Fate Therapeutics
Molecular Templates
Sorrento Therapeutics
Flag link:
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
Fierce Pharma
M&A
antitrust
FTC
Sanofi
Provention Bio
Pfizer
Seagen
Flag link:
Pfizer escapes proposed class action lawsuit over patient copay assistance
Pfizer escapes proposed class action lawsuit over patient copay assistance
Fierce Pharma
Pfizer
legal
copay asssistance programs
Vyndaqel
Vyndamax
Flag link:
Biopharma stocks go back to bleak
Biopharma stocks go back to bleak
EP Vantage
Albireo Pharma
Amryt Pharma
Apellis Pharmaceuticals
AstraZeneca
BridgeBio
Novo Nordisk
Pfizer
Protagonist Therapeutics
Provention Bio
Reata Pharmaceuticals
Regeneron
Sanofi
Seagen
Flag link:

Pages